Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Dow
McKinsey
Merck
Farmers Insurance
Daiichi Sankyo
Covington
US Army
Federal Trade Commission

Generated: June 25, 2018

DrugPatentWatch Database Preview

HYLOREL Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Hylorel, and what generic alternatives are available?

Hylorel is a drug marketed by Pharmacia And Upjohn and is included in one NDA.

The generic ingredient in HYLOREL is guanadrel sulfate. There is one drug master file entry for this compound. Additional details are available on the guanadrel sulfate profile page.
Summary for HYLOREL
Drug patent expirations by year for HYLOREL
Synonyms for HYLOREL
(1,4-Dioxaspiro(4.5)dec-2-ylmethyl)guanidine
(1,4-Dioxaspiro(4.5)dec-2-ylmethyl)guanidine sulfate (2:1)
1-(1,4-dioxaspiro[4.5]dec-2-ylmethyl)guanidine
1-(1,4-dioxaspiro[4.5]dec-2-ylmethyl)guanidine sulfate
1-{1,4-dioxaspiro[4.5]decan-2-ylmethyl}guanidine
2-(1,4-dioxaspiro[4.5]dec-2-ylmethyl)guanidine sulfate(2:1)
2-(1,4-dioxaspiro[4.5]decan-3-ylmethyl)guanidine
2-(1,4-dioxaspiro[4.5]decan-3-ylmethyl)guanidine; sulfuric acid
2-{1,4-dioxaspiro[4.5]decan-2-ylmethyl}guanidine
22195-34-2
22195-34-2 (sulfate[2:1])
2C10H19N3O2.H2O4S
40580-59-4
40580-59-4 (Parent)
AB00513917
AB00513917_02
AC1L1ZYH
AC1L29ZD
AKOS026777091
Anarel
API0008087
BIS(GUANADREL); SULFURIC ACID
bis{amino[(1,4-dioxaspiro[4.5]dec-2-ylmethyl)amino]methaniminium} sulfate
BPBio1_000896
BSPBio_000814
C07035
C10H19N3O2
CAS-22195-34-2
CCG-213544
CCG-220767
CHEBI:5555
CHEBI:5556
CHEMBL1037
CHEMBL1200594
CHEMBL3184143
CL 1388R
CL-1388R
CTK8A7079
D00607
D08029
D0U3CR
DB00226
DR003156
DSSTox_CID_25432
DSSTox_GSID_45432
DSSTox_RID_80874
DTXSID2048533
DTXSID8045432
FT-0669066
GTPL7193
GUANADREL
Guanadrel (INN)
Guanadrel [INN]
Guanadrel Hemisulfate
Guanadrel sulfate
guanadrel sulfate (2:1)
Guanadrel sulfate (USP)
Guanadrel sulfate [USAN:USP]
Guanadrel sulfate [USAN]
Guanadrelum
Guanadrelum [INN-Latin]
Guanidine (1,4-dioxaspiro(4.5)dec-2-ylmethyl)-, sulfate (2:1)
HE326217
HMS1570I16
HMS2097I16
HSDB 6536
Hylorel (TN)
Hyloride
KB-125331
L001259
LS-173930
LS-174846
MCULE-3794032460
N-(1,4-dioxaspiro[4.5]dec-2-ylmethyl)guanidine sulfate(2:1)
NCGC00016758-01
NCGC00179419-01
NSC-760062
NSC760062
Pharmakon1600-01505544
Prestwick0_000767
Prestwick1_000767
Prestwick2_000767
Prestwick3_000767
SCHEMBL1649864
SCHEMBL180963
SCHEMBL41051
SPBio_002753
SR-01000944213
SR-01000944213-1
Tox21_110595
U 28,288D
U 28288D
U-28,288D
U-28288D

US Patents and Regulatory Information for HYLOREL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmacia And Upjohn HYLOREL guanadrel sulfate TABLET;ORAL 018104-001 Dec 29, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Pharmacia And Upjohn HYLOREL guanadrel sulfate TABLET;ORAL 018104-002 Dec 29, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

Expired US Patents for HYLOREL

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pharmacia And Upjohn HYLOREL guanadrel sulfate TABLET;ORAL 018104-001 Dec 29, 1982 ➤ Sign Up ➤ Sign Up
Pharmacia And Upjohn HYLOREL guanadrel sulfate TABLET;ORAL 018104-002 Dec 29, 1982 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Chubb
Teva
UBS
Mallinckrodt
Daiichi Sankyo
Colorcon
Citi
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.